A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome

Abstract

BACKGROUND The Proteus syndrome is characterized by the overgrowth of skin, connective tissue, brain, and other tissues. It has been hypothesized that the syndrome is caused by somatic mosaicism for a mutation that is lethal in the nonmosaic state. METHODS We performed exome sequencing of DNA from biopsy samples obtained from patients with the Proteus syndrome and compared the resultant DNA sequences with those of unaffected tissues obtained from the same patients. We confirmed and extended an observed association, using a custom restriction-enzyme assay to analyze the DNA in 158 samples from 29 patients with the Proteus syndrome. We then assayed activation of the AKT protein in affected tissues, using phosphorylation-specific antibodies on Western blots. RESULTS Of 29 patients with the Proteus syndrome, 26 had a somatic activating mutation (c.49G→A, p.Glu17Lys) in the oncogene AKT1, encoding the AKT1 kinase, an enzyme known to mediate processes such as cell proliferation and apoptosis. Tissues and cell lines from patients with the Proteus syndrome harbored admixtures of mutant alleles that ranged from 1% to approximately 50%. Mutant cell lines showed greater AKT phosphorylation than did control cell lines. A pair of single-cell clones that were established from the same starting culture and differed with respect to their mutation status had different levels of AKT phosphorylation. CONCLUSIONS The Proteus syndrome is caused by a somatic activating mutation in AKT1, proving the hypothesis of somatic mosaicism and implicating activation of the PI3K–AKT pathway in the characteristic clinical findings of overgrowth and tumor susceptibility in this disorder. (Funded by the Intramural Research Program of the National Human Genome Research Institute.)

Goltz syndrome in males: A clinical report of a male patient carrying a novel PORCN variant and a review of the literature

“…We conclude that the mutation exists in both affected and unaffected tissue, but in a higher percentage in affected tissue. It has been observed in other mosaic disorders that the mutation percentage may vary and that mutations can occur even in seemingly unaffected tissue 9, 10…”

Reliable detection of subclonal single-nucleotide variants in tumour cell populations

“…It may be utilised for the analysis of pathogen populations, such as viruses or bacteria, for the assessment of T-cell diversity 22 , or for detecting rare somatic mutations associated with diseases, such as the Proteus syndrome 23 . Another application is the cost-effective pooled sequencing of multiple individuals.…”

Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung

“…For example, Proteus syndrome, a congenital disease involving overgrowth of skin, muscles, fatty tissues, and blood vessels, as well as pulmonary cysts and venous dilatation, is caused by somatic mosaic mutations of AKT1 p.E17K (37). Afflicted individuals are at increased risk for developing benign tumors of the ovary, meninx, and the parotid gland.…”